• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Teflon subproducts recycled into valuable pharmaceuticals

Bioengineer by Bioengineer
February 21, 2017
in Science News
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Public Domain

Fluoroform is highly pollutant, greenhouse effect chemical compound made of carbon and fluorine atoms. It is generated as one of the main waste products in the preparation of popular anti-adherent polymer Teflon. Eliminating fluoroform is expensive, mostly because it is a very good flame retardant, hence burning it is almost impossible.

Nevertheless, ICIQ researchers led by Prof. Vladimir Grushin saw in fluoroform a opportunity, a seam of cheap fluorinated compounds. Taking advantage of a product that is usually wasted, chemists developed a method to obtain organic compounds modified with fluorine atoms. These compounds can be used to prepare all sort of added-value products from drugs -like popular antidepressant Prozac®¬ and several prostate cancer treatments- to agrochemicals and new materials.

Patent Offices from the US and the EU granted ICIQ the exclusive rights over this new synthesis method. Currently, ICIQ is looking for allies in the chemical and pharmaceutical industries to licence and exploit this new and original waste-valorisation technology.

###

Media Contact

Fernando Gomollón-Bel
[email protected]
34-977-920-200 x370
@ICIQchem

http://www.iciq.es/

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Revolutionizing Blood Cancer Treatment: Reprogramming Cancer Cell Death to Activate the Immune System

October 10, 2025

LED Light Targets and Destroys Cancer Cells While Protecting Healthy Tissue

October 10, 2025

Upcoming Release: The Journal of Nuclear Medicine Ahead-of-Print Highlights – October 10, 2025

October 10, 2025

Wirth Named Fellow of the American Physical Society

October 10, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1196 shares
    Share 478 Tweet 299
  • New Study Reveals the Science Behind Exercise and Weight Loss

    102 shares
    Share 41 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    96 shares
    Share 38 Tweet 24
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    83 shares
    Share 33 Tweet 21

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionizing Blood Cancer Treatment: Reprogramming Cancer Cell Death to Activate the Immune System

LED Light Targets and Destroys Cancer Cells While Protecting Healthy Tissue

Upcoming Release: The Journal of Nuclear Medicine Ahead-of-Print Highlights – October 10, 2025

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.